<DOC>
	<DOCNO>NCT00088491</DOCNO>
	<brief_summary>This randomize , double-blind study determine well intramuscular ( IM ) olanzapine depot work compare oral olanzapine ; evaluate safety tolerability IM olanzapine depot compare oral olanzapine ; evaluate different dos IM olanzapine depot ; determine blood level IM olanzapine depot patient different point time injection .</brief_summary>
	<brief_title>Comparison Intramuscular Olanzapine Depot Oral Olanzapine Low-Dose Depot Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Patients must schizophrenia Patients must clinically stable antipsychotic medication Patients must retrospectively judged investigator , base clinical interview impression , stable ( respect symptom schizophrenia ) least 4 week entry study Patients must outpatient BPRS positive item score 4 less enter study Female patient childbearing potential must use medically accept mean contraception . Patients must participate clinical trial another investigational drug , include olanzapine , within 1 month ( 30 day ) prior study entry . Female patient must pregnant breastfeed Patients must experience acute , serious , unstable medical condition schizophrenia Patients must require concomitant treatment medication primarily central nervous system activity , include antidepressant , mood stabilizer , anticonvulsant . Patients must substance ( except nicotine caffeine ) dependence within past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>